RecruitingNCT05824988

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

Studying Pulmonary non-tuberculous mycobacterial infection

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Principal Investigator
Wei Sha, MD, Prof
Shanghai Pulmonary Hospital, Shanghai, China
Intervention
Drug exposure(other)
Enrollment
100 enrolled
Eligibility
18 years · All sexes
Timeline
20232026

Study locations (1)

Collaborators

Fudan University · University of Sydney · Karolinska Institutet · Shanghai Municipal Center for Disease Control and Prevention

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05824988 on ClinicalTrials.gov

Other trials for Pulmonary non-tuberculous mycobacterial infection

Additional recruiting or active studies for the same condition.

See all trials for Pulmonary non-tuberculous mycobacterial infection

← Back to all trials